reference/22615211

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22615211

Outgoing Links

Predicate	Object
contentType	Evaluation Study\|Journal Article\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	63
issn	0959-4973
issueIdentifier	1
pageRange	57-63
publicationName	Anti-Cancer Drugs
startingPage	57
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a6430fa0bd4193de1de7b0d1b8a0977c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_079dcb769f826fc289a5460c4b3b8135 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2a02ea5f8fcc005d6b7773077e079458
bibliographicCitation	Nabha SM, Mohammad RM, Wall NR, Dutcher JA, Salkini BM, Pettit GR, Al-Katib AM. Evaluation of combretastatin A-4 prodrug in a non-Hodgkin's lymphoma xenograft model: preclinical efficacy. Anticancer Drugs. 2001 Jan;12(1):57–63. doi: 10.1097/00001813-200101000-00008. PMID: 11272287.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9125e45671beb807ba584111a977ef89 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ac161068853726aa29325ab8dcd4f47 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_483bbf4595b0b3d820052e57b3e7b9bd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_25b0b288200cdf907c62218ee4c30bbb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c40d18fad8182064cf94bdaa05c5a8f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e0855e1775477a611223d91e0626db67 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58e26f0307ddb0bbe42978d391aba7f8
date	200101
identifier	https://pubmed.ncbi.nlm.nih.gov/11272287 https://doi.org/10.1097/00001813-200101000-00008
isPartOf	https://portal.issn.org/resource/ISSN/0959-4973 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1267
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Evaluation of combretastatin A-4 prodrug in a non-Hodgkin’s lymphoma xenograft model: preclinical efficacy
discusses	http://id.nlm.nih.gov/mesh/M0020537 http://id.nlm.nih.gov/mesh/M0017642 http://id.nlm.nih.gov/mesh/M0163664 http://id.nlm.nih.gov/mesh/M0001486
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008228Q000188 http://id.nlm.nih.gov/mesh/D013267Q000494 http://id.nlm.nih.gov/mesh/D023041 http://id.nlm.nih.gov/mesh/D011355Q000494 http://id.nlm.nih.gov/mesh/D000972Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D013267Q000008 http://id.nlm.nih.gov/mesh/D008228Q000473 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D000972Q000008 http://id.nlm.nih.gov/mesh/D008813 http://id.nlm.nih.gov/mesh/D020714 http://id.nlm.nih.gov/mesh/D011355Q000008 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D009389Q000188 http://id.nlm.nih.gov/mesh/D016513 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D002453Q000187
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8390 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_891f6ebba10aff6918f56c0e92caf9ed http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5351344 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9859 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8596 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8388 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135974690

Showing number of triples: 1 to 59 of 59.